Results showed that the release of adenosine triphosphate (ATP) and high-mobility group box 1 (HMGB1), and the expression level of extracellular calreticulin (CRT) in BLNs-treated cancer cells were significantly higher than those in the control (Fig. 3A-D). Here, HMGB1 is linked to cancer.